QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Congress moves to stock workplaces with overdose-reversal kits

H.R. 7479 — WORK to Save Lives Act · Filed by Bonnie Watson Coleman (D-NJ) · 16 cosponsors · Introduced Feb 10, 2026 · Referred to committee

85%
Transparency
Typical bill: 85%
5/100
Hidden-provision risk
Typical bill: 15/100
Public Health Workplace Safety

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill requires the Department of Labor to issue non-binding guidance to private employers on acquiring opioid overdose reversal medication (like naloxone) and offering voluntary annual training to employees on how to use it. It separately mandates that federal agencies themselves must acquire and maintain such medication and offer the same voluntary training to their employees.

Why we flagged it

The bill's operative mechanism is straightforward: it directs the Department of Labor to create guidance and regulations aimed at making opioid overdose reversal medication available in workplaces. This is a public-health intervention, not a regulatory carve-out or industry subsidy.

What the text implies

  • The bill excludes the U.S. Postal Service from the private-employer guidance requirement, creating a gap in coverage for a large federal employer that handles mail and interacts with the public.
  • Voluntary training language may result in low uptake if employers face no enforcement mechanism; effectiveness depends on employer buy-in and follow-through.
  • The bill does not specify funding for medication acquisition or training delivery, leaving cost burden on employers and federal agencies; implementation may vary widely by agency.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Workers gain access to opioid overdose reversal medication and training at their workplace, potentially saving lives during overdose emergencies. The bill imposes no costs on workers and only encourages (for private employers) or requires (for federal agencies) employers to stock a low-cost, life-saving medication and provide training.

Who stands to gain

  • pharmaceutical manufacturers of naloxone/opioid reversal medications
  • workplace safety training providers

Named in the bill

Department of Labor, Occupational Safety and Health Administration (OSHA), Federal agencies, Veterans Health Administration, U.S. Postal Service, Occupational Safety and Health Act of 1970

Where it stands

16 cosponsors: 15 Democrats, 1 Republicans.

  • Feb 10, 2026 — Introduced · Congress.gov: “Introduced in House”
  • Feb 10, 2026 — Referred to House Committee on Education and Workforce · Congress.gov: “Referred to the House Committee on Education and Workforce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

3 lobbying clients named this bill on 3 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $210,555 in lobbying spend. A filing names 12 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 61% of bills with at least one filing.

  • National Council for Behavioral Health — $150,555 on 1 filing
  • Tobacco-free Kids Action Fund Fka Global Health Advocacy Incubator (ghai) — $40,000 on 1 filing
  • Kelley Drye & Warren Llp Obo Tobacco-free Kids Action Fund — $20,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.

How this was measured

Analysis — Quorum's AI read the bill text published by Congress.gov (1,552 characters) on Aug 17, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.

Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.

Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them.

As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.

“Congress moves to stock workplaces with overdose-reversal kits” QuorumCivic. https://share.quorumcivic.app/bill/119/hr7479 Report an error

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record

The week in bills

One email, Sunday: what Congress passed, what it changed, and who paid.

One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.